Clinical Research Directory
Browse clinical research sites, groups, and studies.
Validation Study of the EMILY AI Device in Acute and Chronic Respiratory Failure
Sponsor: Aether Tech S.L.
Summary
Currently, there is no holistic solution for patients with respiratory diseases that includes oxygenation and management of a patient with respiratory disease, combining dynamic and automatic O2 administration and the detection of clinical worsening, generating a diagnostic suspicion, a management proposal, and notifying the medical team. For device validation, prospective studies will be conducted in patients in respiratory intermediate care units, conventional hospitalization, during physical activity in the hospital setting, and in an out-of-hospital setting. The device will be evaluated in terms of oxygenation efficacy, response time, patient safety, efficiency, versatility, clinical benefit, and adaptability.
Official title: Functional, Clinical, and Predictive Validation Study of the EMILY AI Device in Patients With Acute and Chronic Respiratory Failure
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
20
Start Date
2025-04-23
Completion Date
2026-12-30
Last Updated
2026-01-09
Healthy Volunteers
No
Interventions
Emily.AI
EMILY.AI is composed of an O2 regulating valve together with an intelligent system which allows the automation in the regulation of O2 and its customization.
Locations (2)
Hospital Universitario Fundación Jiménez Díaz
Madrid, Spain
Hospital Universitario Fundación Jiménez Díaz
Madrid, Spain